FDA Inspection
Xytex LaboratoriesXytex Laboratories – FDA Inspection, Aug 5, 2022
Record Details
This FDA Inspection record concerns Xytex Laboratories, with an inspection on August 5, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Xytex Laboratories
- Inspection Date
- August 5, 2022
- Product Type
- Biologics
View Company Profile
ID · ca5fa8ae-2a02-4576-ad7c-fa8a5801ec8b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1177571
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Xytex Laboratories
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 21, 2018 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Xytex Laboratories
- FDA Inspection 1248987 - 2024-09-05
- FDA Inspection 1078096 - 2018-12-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.